Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Geddes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Protocols|September 4, 2021
An LC-MS/MS assay and complementary web-based tool to quantify and predict compound accumulation in E. coliEmily J Geddes, Zhong Li, Paul J Hergenrother
ACS Infectious Diseases|November 18, 2023
Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in <i>Pseudomonas aeruginosa</i> Using Split LuciferaseHanling Guo, Emily J Geddes, Timothy J Opperman, et al.
ACS Infectious Diseases|November 24, 2020
Compound Uptake into <i>E. coli</i> Can Be Facilitated by <i>N</i>-Alkyl Guanidiniums and PyridiniumsSarah J Perlmutter, Emily J Geddes, Bryon S Drown, et al.
Journal of the American Chemical Society|May 21, 2020
Gram-Negative Antibiotic Active Through Inhibition of an Essential RiboswitchStephen E Motika, Rebecca J Ulrich, Emily J Geddes, et al.
Nature Microbiology|November 20, 2019
Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogensErica N Parker, Bryon S Drown, Emily J Geddes, et al.
Chemical Science|December 15, 2021
Rationalizing the generation of broad spectrum antibiotics with the addition of a positive chargeNandan Haloi, Archit Kumar Vasan, Emily J Geddes, et al.
Nature|November 22, 2023
Porin-independent accumulation in Pseudomonas enables antibiotic discoveryEmily J Geddes, Morgan K Gugger, Alfredo Garcia, et al.
ACS Infectious Diseases|May 13, 2026
Large-Scale Chemical-Genetic Interaction Profiling Identifies a Small-Molecule Inhibitor of <i>Mycobacterium tuberculosis</i> Polyketide Synthase 13James E Gomez, Matthew Y Solomon, Diana K Hunt, et al.
ACS Central Science|August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative InfectionsErica N Parker, Brett N Cain, Behnoush Hajian, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Protocols|September 4, 2021
An LC-MS/MS assay and complementary web-based tool to quantify and predict compound accumulation in E. coliEmily J Geddes, Zhong Li, Paul J Hergenrother
ACS Infectious Diseases|November 18, 2023
Cell-Based Assay to Determine Type 3 Secretion System Translocon Assembly in <i>Pseudomonas aeruginosa</i> Using Split LuciferaseHanling Guo, Emily J Geddes, Timothy J Opperman, et al.
ACS Infectious Diseases|November 24, 2020
Compound Uptake into <i>E. coli</i> Can Be Facilitated by <i>N</i>-Alkyl Guanidiniums and PyridiniumsSarah J Perlmutter, Emily J Geddes, Bryon S Drown, et al.
Journal of the American Chemical Society|May 21, 2020
Gram-Negative Antibiotic Active Through Inhibition of an Essential RiboswitchStephen E Motika, Rebecca J Ulrich, Emily J Geddes, et al.
Nature Microbiology|November 20, 2019
Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogensErica N Parker, Bryon S Drown, Emily J Geddes, et al.
Chemical Science|December 15, 2021
Rationalizing the generation of broad spectrum antibiotics with the addition of a positive chargeNandan Haloi, Archit Kumar Vasan, Emily J Geddes, et al.
Nature|November 22, 2023
Porin-independent accumulation in Pseudomonas enables antibiotic discoveryEmily J Geddes, Morgan K Gugger, Alfredo Garcia, et al.
ACS Infectious Diseases|May 13, 2026
Large-Scale Chemical-Genetic Interaction Profiling Identifies a Small-Molecule Inhibitor of <i>Mycobacterium tuberculosis</i> Polyketide Synthase 13James E Gomez, Matthew Y Solomon, Diana K Hunt, et al.
ACS Central Science|August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative InfectionsErica N Parker, Brett N Cain, Behnoush Hajian, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 1